Baduanjin
Baduanjin has been studied in 165 papers since 2017: 63 trials and 4 observational studies in people, 78 reviews; 72 in the past year. The newest paper, Nov 13, 2026: “The effects of different traditional Chinese fitness exercises on physical function in the older adults: a network meta-analysis”.
165 papers study it238 findingsUpdated
10 new papers in 30 daysSee all 165 papers on baduanjin
At a glance
Baduanjin improves cognition and physical function in human trials, with independent labs reporting these benefits again; trials also report reduced frailty. Balance results differ, with improvement and no clear effect both reported. Its papers name the National Natural Science Foundation of China among their funders.
238 findings in 90 papers from 2017 to 2026, 14 of them since April 2026
Independent labs found the same change in people. 69 independent labs in 14 countries.
“Baduanjin significantly improved stiffness.”
8 of its findings point the other way.
- 69 independent labs in 14 countries
- 8 findings against
- Funders: National Natural Science Foundation of China and others
- Human trial63
- Humans4
- In silico2
Studies in people
See all 55 studies of baduanjin in people55 studies gave baduanjin to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases WOMAC pain-3.04 points (95% CI -3.78 to -2.30); P < 0.001 up: Improves physical function | Randomized trial12 weeks | 116 peopleolder adultsOlder adults; knee osteoarthritis | Journal of pain research, Nov 6, 2026 |
up: Improves balance up: Improves lower limb muscle strength | Trial6 weeks | 20 peopleWomen45-70 yearsPostmenopausal women; postmenopausal osteoporosis | International Journal of Science and Research (IJSR), Oct 12, 2026 |
up: Improves cognitive function down: Decreases systolic blood pressure | Trial16 weeks | 93 people60–70 yearsOlder adults aged 60–70 years | Frontiers in public health, Aug 20, 2026 |
| Randomized trial12 weeks | 162 peoplebetween 60 and 75 yearsOlder adults living in the community | Frontiers in psychology, Aug 14, 2026 | |
down: Decreases blood pressure | Trial | Older adults; hypertension | JURNAL ILMIAH KESEHATAN SANDI HUSADA, Aug 6, 2026 |
What did studies of baduanjin find?
120Studies of baduanjin measured 120 outcomes; the most studied are cognitive function (25 studies), balance (14) and physical function (10).
Cognitive function
upin humans25+78% ranking probability
25 studies
Cognitive function
upin humans25+78% ranking probability
Baduanjin improves cognitive function in humans (compared with control).
“Both the Baduanjin exercise group and Resistance Band exercise group showed significantly greater improvements than the control group in the total MoCA score and its subdomains (naming, executive function, attention, orientation, and delayed recall) (p < 0.05), though no significant difference was found between the two training groups”
Human trialcompared with control16 weeks
Frontiers in public health
Baduanjin improves cognitive function in humans.
“A 2 × 2 factorial ANOVA examining the main effects of Baduanjin and cognitive training revealed significant main effects of both interventions on global cognition (MoCA), memory (immediate, short-delay, long-delay), reverse digit span, executive function (TMT-B), language (BNT), and visuospatial function (CDT) (p < 0.05, partial η2 range 0.047–0.558”
Human trial12 weeksn = 162
Frontiers in psychology
Baduanjin improves cognitive function in humans (mild cognitive impairment).
“Compared to the control group, the Baduanjin group showed significant improvements in MoCA and MMSE scores after 12 weeks of training”
Human trialmild cognitive impairment12 weeksn = 46
Frontiers in aging neuroscience
Baduanjin improves cognitive function in humans (early- to mid-stage Parkinson's disease) (P = 0.015).
“improved cognition at 6 weeks (P = 0.015).”
Human trialearly- to mid-stage Parkinson's disease6 weeks
Frontiers in neurology
Baduanjin improves cognitive function in humans (combined with CCRT vs CCRT alone).
“intervention group demonstrated significantly greater improvements across all outcome measures (NCSE, SSPI, SQLS, and PANSS) compared to the control group post-intervention (all P < 0.05).”
Human trialcombined with CCRT vs CCRT alone8 weeksn = 120
Research SquarePreprint
Baduanjin improves cognitive function in humans (individuals with subjective cognitive decline) (p < 0.001).
“Both groups showed significant PACC improvement at 3 and 6 months (p < 0.001)”
Human trialindividuals with subjective cognitive declineremote6 months
Remote Baduanjin improves cognition and Hippocampal Connectivity in Subjective Cognitive Decline
GSA 2025 abstract
Baduanjin improves cognitive function in humans.
“In addition, both the Baduanjin and BW groups showed advantages in global cognition relative to the HE group (p < 0.01, η2 = 0.34).”
Human trial12 weeks
Healthcare (Basel, Switzerland)
Baduanjin improves cognitive function in humans (subclinical hypothyroidism and mild cognitive impairment, receiving 12-week levothyroxine).
“Adding Baduanjin to pharmacotherapies of SCH not only improves blood pressure, TSH, lipids, and BMI, but also improves MCI in older women.”
Human trialsubclinical hypothyroidism and mild cognitive impairment, receiving 12-week levothyroxinefemalesn = 40
Geriatric nursing (New York, N.Y.)
Baduanjin improves cognitive function in humans (F = 37.24, partial η2 = 0.47).
“There was a significant Time × Group interaction (F = 37.24, p < 0.05, partial η2 = 0.47), indicating that the BG improved more than the CG after 12-week intervention.”
Human trial12 weeksn = 40
Frontiers in physiology
Baduanjin improves cognitive function in humans (older adults with low physical activity levels).
“12-week Baduanjin intervention in a blended online-offline model can significantly improve cognitive function in the older adults.”
Human trialolder adults with low physical activity levels60 min, 3 times per week12 weeksn = 40
Frontiers in physiology
All 28Fewer
Balance
upin humans13no changein humans1
14 studies
Balance
upin humans13no changein humans1
Baduanjin improves balance in humans (postmenopausal osteoporosis).
“Both groups demonstrated statistically significant improvement in balance and muscle strength (p < 0.05).”
Human trialpostmenopausal osteoporosis6 weeksfemalesn = 20
International Journal of Science and Research (IJSR)
Baduanjin improves balance in humans (radiographic knee osteoarthritis; added to structured exercise therapy).
“Both Baduanjin groups showed significant improvements in VAS, WOMAC, BBS, Timed Up and Go, kinesiophobia, and sit-to-stand performance at weeks 6 and 12”
Human trialradiographic knee osteoarthritis; added to structured exercise therapyface-to-face or onlinethree times weekly6 and 12 weeks
Journal of back and musculoskeletal rehabilitation
Baduanjin showed no clear effect on balance in humans (early- to mid-stage Parkinson's disease) (all P > 0.05).
“No between-group differences occurred in limb subscale or BBS (all P > 0.05).”
Human trialearly- to mid-stage Parkinson's disease12 weeks
Frontiers in neurology
Baduanjin improves balance in humans.
“The resistance band group outperformed the control group in gait speed and SPPB (P<0.05), while the Baduanjin group showed greater gains than the control group in balance (P<0.05).”
Human trial12-week intervention period
Medical science monitor : international medical journal of experimental and clinical research
Baduanjin improves balance in humans.
“In terms of functional mobility, the standard TUG (p < 0.01, η2 = 0.33) showed that Baduanjin had faster completion times than both BW and HE at post-test and follow-up.”
Human trial12 weeks
Healthcare (Basel, Switzerland)
Baduanjin improves balance in humans.
“In addition, the reduction of SPT [F (1,22) = 6.62, p = 0.01] and SPC [F (1,22) = 6.20, p = 0.01] in the Baduanjin group was more than that in the control group”
Human trial12 weeksn = 46
Preventive medicine reports
Baduanjin improves balance in humans (p < 0.05).
“The Baduanjin group demonstrated improved performance in the sway path balance test compared to the control group, particularly in the coronal plane (p < 0.05).”
Human trialn = 42
Preventive medicine reports
Baduanjin improves balance in humans (mild to moderate PD).
“After exercise, the total score of patients was higher, and the grade was better.”
Human trialmild to moderate PD3 weeksn = 27
Frontiers in neuroscience
Baduanjin improves balance in humans (mild to moderate Parkinson's disease) (total score t = -2.147, P = 0.041; grade t = 3.432, P = 0.002).
“Balance-check® indicators, including the total score (t = -2.147, P = 0.041) and grade (t = 3.432, P = 0.002) significantly differed before and after exercise.”
Human trialmild to moderate Parkinson's disease3 weeksn = 31
Frontiers in neuroscience
Baduanjin improves balance in humans (chronic stroke; compared with conventional fitness training).
“Significantly greater improvements in the Mini-Balance Evaluation Systems Test (Mini-BESTest), composite equilibrium score (Sensory Organization Test)”
Human trialchronic stroke; compared with conventional fitness training8 weeksn = 58
Neurorehabilitation and neural repair
All 16Fewer
Physical function
upin humans10
10 studies
Physical function
upin humans10
Baduanjin improves physical function in humans (knee osteoarthritis; compared with health education).
“Regular TC and BDJ practice effectively improved the pain, stiffness, and physical function of older adults with KOA”
Human trialknee osteoarthritis; compared with health education
Journal of pain research
Baduanjin improves physical function in humans (radiographic knee osteoarthritis; added to structured exercise therapy).
“Both Baduanjin groups showed significant improvements in VAS, WOMAC, BBS, Timed Up and Go, kinesiophobia, and sit-to-stand performance at weeks 6 and 12”
Human trialradiographic knee osteoarthritis; added to structured exercise therapyface-to-face or onlinethree times weekly6 and 12 weeks
Journal of back and musculoskeletal rehabilitation
Baduanjin improves physical function in humans (SUCRA ranking in Bayesian network meta-analysis) (WOMAC Function SUCRA 0.84).
“For improving joint stiffness (WOMAC Stiffness SUCRA: 0.90) and physical function (WOMAC Function SUCRA: 0.84), Baduanjin was the most effective.”
Human trialSUCRA ranking in Bayesian network meta-analysis
Frontiers in public health
Baduanjin improves physical function in humans.
“The 30CST (p < 0.01, η2 = 0.23) similarly revealed that both Baduanjin and BW demonstrated greater lower-limb strength than HE at post-test, and these benefits were maintained at follow-up.”
Human trial12 weeks
Healthcare (Basel, Switzerland)
Baduanjin improves physical function in humans.
“The experimental group maintained their functional abilities, whereas the control group experienced marked declines.”
Human trial12 weeks
Complementary therapies in medicine
Baduanjin improves physical function in humans (postoperative rehabilitation of vertebral or hip fractures).
“Elevated FMA, BI and BBS scores were observed in both groups after rehabilitation training, with more evident elevations in RG”
Human trialpostoperative rehabilitation of vertebral or hip fracturesn = 106
Biotechnology & genetic engineering reviews
Baduanjin improves physical function in adults with mild-to-moderate intellectual disabilities (p = .010).
“Participants in the Baduanjin group experienced significant changes in the SPPB walking test (p = .042), chair stand test (p = .015), and SPPB summary score (p = .010).”
Human trialin adults with mild-to-moderate intellectual disabilities9-monthsn = 18
Journal of applied research in intellectual disabilities : JARID
Baduanjin improves physical function in humans (multiple sclerosis) (P < 0.05).
“For BBS and TIS, there were significant changes pre- to post- exercise in two exercise groups (P < 0.05), with greater increases in the Baduanjin exercise group (BDJ group).”
Human trialmultiple sclerosis24-weekn = 30
Complementary therapies in medicine
Baduanjin improves physical function in humans (pre-post comparison without control group; no statistics reported).
“There post-training outcomes in hand grip strength, knee extension strength, TUG, MQ, FES, MoCA, GDS, and EQ-5D-5L index score appeared to be better.”
Human trialpre-post comparison without control group; no statistics reported2×/week in the first 4 weeks and 3×/week thereafter16 weeks
Pilot and feasibility studies
Baduanjin improves physical function in humans.
“The aggregated results showed significant benefits of Baduanjin on physical function, walking ability, balance, and anxiety.”
Review
Journal of applied gerontology : the official journal of the Southern Gerontological Society
Quality of life
upin humans7no changein humans1
8 studies
Quality of life
upin humans7no changein humans1
Baduanjin improves quality of life in humans (91.23 ± 6.78 versus 87.89 ± 7.01; reported interval [2.155, 4.525]).
“significantly higher quality of life scores (91.23 ± 6.78, 87.89 ± 7.01, P < .001)”
Human triallung cancer after video-assisted thoracoscopic surgery; compared with bedside cycle ergometer trainingn = 520
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Baduanjin improves quality of life in humans.
“The SF-36 scale scores were significantly higher in the observation group than the control group, including mental health, vitality, role-physical, and physical functioning (P <.001, Table ).”
Human trial8 weeksn = 247
Medicine
Baduanjin improves quality of life in humans.
“Baduanjin exercise training also significantly improved the quality of life, as measured by the PDQ-39 (p = 0.042) ( C), in PD patients compared to control group.”
Human trial4-weekn = 60
Clinical parkinsonism & related disorders
Baduanjin improves quality of life in humans (postoperative rehabilitation of vertebral or hip fractures).
“In addition, RG was observed with fewer adverse reactions and higher SF-36 scores (P < 0.05).”
Human trialpostoperative rehabilitation of vertebral or hip fracturesn = 106
Biotechnology & genetic engineering reviews
Baduanjin improves quality of life in humans.
“A significant change in the group–time interaction was determined (P < 0.001), suggesting that the changing trend in QOL-DA scores varied depending on the intervention.”
Human trial8 weeksmalesn = 60
Frontiers in public health
Baduanjin showed no clear effect on quality of life in humans (chronic stroke).
“Other outcomes (Limit of Stability, Fall-Efficacy Scale, Modified Barthel Index, Stroke-Specific Quality of Life) showed no significant results”
Human trialchronic stroke16 weeksn = 58
Neurorehabilitation and neural repair
Baduanjin is linked with better quality of life in humans (hemiplegia after stroke).
“The mental health, vitality, physical role, and physical function scores of the observation group were significantly higher than those of the control group after 8 weeks of intervention.”
Humanshemiplegia after stroke8 weeksn = 185
Medicine
Baduanjin improves quality of life in humans (compared with placebo).
“Compared with placebo, Baduanjin significantly improved cognition, quality of life (general health), and quality of life (mental health).”
Reviewcompared with placebo
European Journal of Integrative Medicine
Baduanjin improves quality of life in humans (SMD = 0.73, 95% CI: 0.29-1.18).
“Significant improvements were also observed in quality of life (SMD = 0.73, 95% CI: 0.29-1.18, p = 0.001)”
Review
Frontiers in public health
Frailty
downin humans5
5 studies
Frailty
downin humans5
Baduanjin decreases frailty in humans.
“Between-group comparisons indicated that frailty scores were significantly lower in both the Baduanjin and the combined groups compared with the vitamin D group (p < 0.05).”
Human trial3 months
Nutrients
Baduanjin decreases frailty in humans (residents of long-term care facilities) (1.43 ± 0.90 vs 2.65 ± 0.79, p < 0.05).
“frailty phenotype scores were significantly lower in the Baduanjin (1.43 ± 0.90, p < 0.05) and combined (1.08 ± 1.10, p < 0.05) groups compared with the vitamin D group”
Human trialresidents of long-term care facilities3-month
Nutrients
Baduanjin decreases frailty in humans (older adults with cognitive frailty).
“EFS scores in Baduanjin group were averagely decreased by 1.9 points (SD = 0.20) and significantly (p = 0.012) lower than that in the control group”
Human trialolder adults with cognitive frailty24 weeksn = 102
Frontiers in public health
Baduanjin decreases frailty in humans (cognitive frailty) (1.94 ± 0.20 points, p = 0.012).
“decreased EFS scores (1.94 ± 0.20 points, p = 0.012) in the Baduanjin group were significantly higher than those in the control group”
Human trialcognitive frailty24 weeksn = 102
Frontiers in public health
Baduanjin decreases frailty in humans (cognitive frailty) (P = 0.004).
“Montreal Cognitive Assessment and Edmonton Frail Scale scores, also showed significant improvement (P = 0.002 and P = 0.004)”
Human trialcognitive frailty60 min sessions three times per week24 weeksn = 120
Clinical rehabilitation
Baduanjin decreases frailty in humans (-1.94 vs -1.16).
“the average EFS scores were decreased 1.94 scores (SE, 0.20) in the BEG, significantly lower than in the CG (−1.16 ± 0.23; P = 0.012”
Human trial24 weeksn = 102
Journal of exercise science and fitness
Baduanjin decreases frailty in humans (cognitive frailty).
“the increase in MoCA scores and the decrease in EFS scores were significantly higher in the BEG than in the CG”
Human trialcognitive frailty24 weeksn = 102
Journal of exercise science and fitness
Baduanjin decreases frailty in humans (mild cognitive impairment) (SMD = -0.97, 95% CI -1.30 to -0.64, p < 0.001).
“frailty (Edmonton Frailty Scale; SMD = -0.97; 95% CI, -1.30, -0.64; p < 0.001) were all improved with BE for older adults with MCI.”
Reviewmild cognitive impairmentn = 994
The Journal of nervous and mental disease
Pain
downin humans4
4 studies
Pain
downin humans4
Baduanjin decreases pain in humans (radiographic knee osteoarthritis; added to structured exercise therapy).
“Both Baduanjin groups showed significant improvements in VAS, WOMAC, BBS, Timed Up and Go, kinesiophobia, and sit-to-stand performance at weeks 6 and 12”
Human trialradiographic knee osteoarthritis; added to structured exercise therapyface-to-face or onlinethree times weekly6 and 12 weeks
Journal of back and musculoskeletal rehabilitation
Baduanjin decreases pain in humans (postoperative rehabilitation of vertebral or hip fractures).
“VAS score reduced markedly and was lower in RG compared with CG (P < 0.05).”
Human trialpostoperative rehabilitation of vertebral or hip fracturesn = 106
Biotechnology & genetic engineering reviews
Baduanjin decreases pain in senile osteoporosis, combined with conventional treatment.
“BDJ exercise combined with conventional treatment can improve the BMD of hip and pain relieve (VAS).”
Reviewin senile osteoporosis, combined with conventional treatment
Baduanjin exercise: A potential promising therapy toward osteoporosis
Frontiers in medicine
Baduanjin decreases pain in humans.
“A long-term Baduanjin intervention could also improve quality of life and reduce falls and pain.”
Reviewlong-term
Journal of applied gerontology : the official journal of the Southern Gerontological Society
Grip strength
upin humans4
4 studies
Grip strength
upin humans4
Baduanjin improves grip strength in humans (p < 0.05).
“Linear mixed-effects analysis revealed significant between-group differences in grip strength, gait speed, cadence, and load ratio after 12 weeks (p < 0.05).”
Human trial12 weeks
Complementary therapies in medicine
Baduanjin improves grip strength in humans (elderly lung cancer patients undergoing chemotherapy).
“The exercise group improved CRF, grip strength, and gait speed at 12 weeks.”
Human trialelderly lung cancer patients undergoing chemotherapy12 weeks
Experimental gerontology
Baduanjin improves grip strength in humans (frail or prefrail) (MD 2.39 kg; 95% CI 2.17 to 2.62; P < 0.001).
“improved physical function outcomes, including grip strength (MD = 2.39 kg, 95% CI: 2.17 to 2.62, P < 0.001)”
Reviewfrail or prefrail
Media Publikasi Promosi Kesehatan Indonesia (MPPKI)
Baduanjin improves grip strength in humans (frail and pre-frail) (MD = 2.51, 95% CI [1.09, 3.93], p < 0.01).
“grip strength enhanced doing Badaunjin (MD = 2.51, 95% CI [1.09, 3.93]; p < 0.01)”
Reviewfrail and pre-frail
The Journal of frailty & aging
Gait
upin humans3
3 studies
Gait
upin humans3
Baduanjin improves gait in humans (early- to mid-stage Parkinson's disease) (all P < 0.05).
“Baduanjin showed superior gait parameters including TUG duration, turning time, trunk sagittal angular velocity during sit-to-stand/stand-to-sit; (all P < 0.05).”
Human trialearly- to mid-stage Parkinson's disease12 weeks
Frontiers in neurology
Baduanjin improves gait in humans (mild to moderate PD).
“Among these parameters, step duration (t = 2.289, P = 0.030) and cycle duration (t = 2.181, P = 0.038) were significantly lower after Baduanjin exercise.”
Human trialmild to moderate PD3 weeksn = 27
Frontiers in neuroscience
Baduanjin improves gait in humans (mild to moderate Parkinson's disease) (step duration t = 2.289, P = 0.030; cycle duration t = 2.181, P = 0.038).
“Gait parameters like step (t = 2.289, P = 0.030) and cycle (t = 2.181, P = 0.038) durations also significantly improved”
Human trialmild to moderate Parkinson's disease3 weeksn = 31
Frontiers in neuroscience
Baduanjin improves gait in humans (Parkinson's disease) (MD 21.62, 95% CI 11.14 to 32.10, p<0.0001).
“Baduanjin significantly improved the gait of patients with PD, based on the 6 min walk distance (MD 21.62, 95% CI 11.14 to 32.10, p<0.0001)”
ReviewParkinson's disease
BMJ open
Sleep quality
upin humans3
3 studies
Sleep quality
upin humans3
Baduanjin improves sleep quality in humans (fibromyalgia syndrome) (MD -1.65 points, P = 0.001).
“sleep quality (PSQI; MD, -1.65 points; P = 0.001)”
Human trialfibromyalgia syndrome30 min daily4 weeksn = 74
Complementary therapies in medicine
Baduanjin improves sleep quality in humans (sleep disturbances) (PSQI endpoint-to-baseline change = - 2.6 ± 4.0 vs. - 0.5 ± 4.2, p = 0.007).
“The intervention group reported significant improvements in overall sleep quality after 24 weeks compared with those randomized to control”
Human trialsleep disturbancesfive 45-min sessions per week24 weeksn = 139
Sleep & breathing = Schlaf & Atmung
Baduanjin improves sleep quality in humans (MD = -2.81, 95% CI: -3.38 to -2.24).
“Pooled analyses showed that Baduanjin significantly improved sleep quality (MD = -2.81, 95% CI: -3.38 to -2.24, p < 0.001)”
Review
Frontiers in public health
Executive function
upin humans3
3 studies
Executive function
upin humans3
Baduanjin improves executive function in humans (mild cognitive impairment).
“along with significant reductions in STT-B completion time, SCL-90 scores, and PSQI scores”
Human trialmild cognitive impairment12 weeksn = 46
Frontiers in aging neuroscience
Baduanjin improves executive function in humans (cognitive frailty) (all P < 0.05).
“the scores of Clock Drawing Test and Verbal Fluency Test, the Trail Making Test-B time and the Card correct numbers of Stroop Test in Baduanjin training group showed significant improvement”
Human trialcognitive frailty60 min sessions three times per week24 weeksn = 120
Clinical rehabilitation
Baduanjin improves executive function in humans.
“including general memory and its sub-domains (i.e., immediate memory and delayed memory), executive function, and processing speed”
Review
Complementary therapies in medicine
Gait speed
upin humans2
2 studies
Gait speed
upin humans2
Baduanjin improves gait speed in humans (compared with resistance training) (B = 0.41 [95% CI, 0.01–0.81]).
“At T2, notable improvements were again observed in BE, with significant increases in SPPB (B = 1.94 [95% CI, 1.20–2.68]), balance (B = 0.76 [95% CI, 0.31–1.22]), lower limb muscular ability (B = 0.75 [95% CI, 0.25–1.24]) and gait speed (B = 0.41 [95% CI, 0.01–0.81]).”
Human trialcompared with resistance training24 weeksn = 90
Efficacy of Baduanjin Exercise for Sarcopenia in Older Adults: A 24-Week Randomized Controlled Trial
Journal of cachexia, sarcopenia and muscle
Baduanjin improves gait speed in humans (primary sarcopenia) (B = 0.41 [95% CI, 0.01-0.81]).
“gait speed (B = 0.41 [95% CI, 0.01-0.81])”
Human trialprimary sarcopenia60-minute sessions, three times a week24 weeksn = 90
Efficacy of Baduanjin Exercise for Sarcopenia in Older Adults: A 24-Week Randomized Controlled Trial
Journal of cachexia, sarcopenia and muscle
Baduanjin improves gait speed in humans (elderly lung cancer patients undergoing chemotherapy).
“The exercise group improved CRF, grip strength, and gait speed at 12 weeks.”
Human trialelderly lung cancer patients undergoing chemotherapy12 weeks
Experimental gerontology
Muscle strength
upin humans2
2 studies
Muscle strength
upin humans2
Baduanjin increases muscle strength in humans.
“The repeated measures analysis of variance results exhibited greater improvements in maximum isometric knee extensor strength of the Baduanjin group than the control group, indicating a significant interaction [F (1,22) = 3.63, p = 0.03].”
Human trial12 weeksn = 46
Preventive medicine reports
Baduanjin increases muscle strength in humans (p < 0.05).
“and their maximum isometric strength of the knee extensor (p < 0.05).”
Human trialn = 42
Preventive medicine reports
Baduanjin improves muscle strength in humans (SMD = 0.63, 95% CI 0.22 to 1.04, p = 0.003).
“Baduanjin significantly improved muscle strength (grip strength: SMD = 0.63, 95% CI 0.22 to 1.04, p = 0.003)”
Review
BMC complementary medicine and therapies
Memory function
upin humans2
2 studies
Memory function
upin humans2
Baduanjin improves memory function in humans (Baduanjin: p < 0.001).
“Post hoc Sidak correction analysis showed that compared with the control group, MQ scores significantly increased in the TCC and Baduanjin groups (Baduanjin: p < 0.001, TCC: p < 0.001).”
Human trial12 weeksn = 90
Frontiers in human neuroscience
Baduanjin improves memory function in humans.
“TCC and Baduanjin groups demonstrated significant improvements in memory function”
Human trial12 weeks
Frontiers in human neuroscience
Baduanjin improves memory function in humans.
“The Baduanjin group showed significant increases in mental control, recognition, visual reproduction touch, and comprehension memory subscores compared with the control group following Bonferroni correction (0.0063).”
Human trial12-weeks
Tai Chi Chuan and Baduanjin Increase Grey Matter Volume in Older Adults: A Brain Imaging Study
Journal of Alzheimer's disease : JAD
Systolic blood pressure
downin humans2
2 studies
Systolic blood pressure
downin humans2
Baduanjin decreases systolic blood pressure in humans (compared with resistance training).
“Additionally, the Baduanjin exercise group experienced more favorable improvements improvements in systolic blood pressure compared with the Resistance Band exercise group (p < 0.001), possibly due to the breathing regulation and sympathetic nervous system inhibition inherent in Baduanjin movements.”
Human trialcompared with resistance training16 weeks
Frontiers in public health
Baduanjin decreases systolic blood pressure in humans (essential hypertension) (-11.4 mmHg).
“Baduanjin significantly reduced SBP by 8.3 mmHg (3 months), 11.4 mmHg (6 months), and 5.4 mmHg (12 months)”
Reviewessential hypertension6 monthsn = 1,994
Complementary therapies in medicine
Postural balance
upin humans2
2 studies
Postural balance
upin humans2
Baduanjin improves postural balance in humans (compared with control).
“Post-hoc analyses indicated that after the intervention, both the Baduanjin and Resistance Band exercise groups improved their balance, whereas the control group showed declines to varying degrees.”
Human trialcompared with control16 weeks
Frontiers in public health
Baduanjin improves postural balance in humans (effect size d ≈1.57).
“The Offline group also showed immediate balance enhancement (closed-eye stance improvement, effect size d ≈1.57)”
Human trial12 weeksfemalesn = 27
Applied Sciences
All 120Fewer
What is baduanjin linked with?
3Studies link baduanjin with 3 measures: cardiovascular adverse events, fall risk and accidental falls.
Cardiovascular adverse events
downin humans1RR 0.4
1 study
Cardiovascular adverse events
downin humans1RR 0.4
Baduanjin lowers the risk of cardiovascular adverse events in humans (RR = 0.40, 95% CI (0.25, 0.65)).
“Baduanjin did not appear to increase the risk of adverse events and may even reduce the incidence of certain cardiovascular adverse events”
Reviewpatients who have undergone percutaneous coronary intervention following an acute myocardial infarction
Complementary therapies in medicine
Fall risk
downin humans1
1 study
Fall risk
downin humans1
Baduanjin lowers the risk of fall risk in humans.
“Also, there was a significant decrease in the TUG in both groups (P <.05), but the decrease in the experimental group was greater than in the control group, as presented in Tables and.”
Human trial8 weeksn = 60
Medicine
Accidental falls
downin humans1
1 study
Accidental falls
downin humans1
Baduanjin lowers the risk of accidental falls in humans (SMD = -2.19, 95% CI -3.35–-1.04).
“Additionally, the findings indicated a notable reduction in the risk of falls (SMD = -2.19, 95%CI: -3.35--1.04)”
Review
Frontiers in public health
Funding
2 grants since 2019National Institute on Aging$4MHealth and Medical Research FundHK$1.4M
How this record changed
Summary rewritten as its findings changed.
As it read before
Baduanjin reduces frailty in human trials, while independent labs report improvements in cognition and physical function. A trial in people with subjective cognitive decline reports unchanged everyday cognition, while a 16-week trial reports unchanged knee-extension strength and fear of falling. Oxidative-stress markers in cognitive frailty change in both directions.
Summary rewritten as its findings changed.
As it read before
Human trials show Baduanjin improves cognition; one 16-week trial also reports better postural balance and lower systolic blood pressure. A review describes reduced depressive symptoms and body mass index, and improved quality of life, sleep quality and handgrip strength.
Summary written from the findings.